Results 151 to 160 of about 514,814 (311)
Generating ball trajectory in soccer video sequences
This paper demonstrates innovative techniques for estimating the trajectory of a soccer ball, using fixed cameras with constant calibration parameters.
Orwell, James +4 more
core
Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes
ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini +28 more
wiley +1 more source
Predicting rare events using neural networks and short-trajectory data. [PDF]
Strahan J, Finkel J, Dinner AR, Weare J.
europepmc +1 more source
Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao +6 more
wiley +1 more source
A Comparative Study of Frequent Pattern Mining with Trajectory Data. [PDF]
Ding S, Li Z, Zhang K, Mao F.
europepmc +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
Experiments and Analyses of Anonymization Mechanisms for Trajectory Data Publishing. [PDF]
Sun S +5 more
europepmc +1 more source
Tracking Data Trajectories in IoT
Chiara Bodei, Letterio Galletta
openaire +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Evaluation of Roadside LiDAR-Based and Vision-Based Multi-Model All-Traffic Trajectory Data. [PDF]
Guan F, Xu H, Tian Y.
europepmc +1 more source

